Early versus deferred standard androgen suppression therapy for advanced hormone‐sensitive prostate cancer

BACKGROUND: Standard androgen suppression therapy (AST) using surgical or medical castration is considered a mainstay of advanced hormone‐sensitive prostate cancer treatment. AST can be initiated early when disease is asymptomatic or deferred when patients suffer symptoms of disseminated prostate ca...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Kunath, Frank, Jensen, Katrin, Pinart, Mariona, Kahlmeyer, Andreas, Schmidt, Stefanie, Price, Carrie L, Lieb, Verena, Dahm, Philipp
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2019
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6564091/
https://ncbi.nlm.nih.gov/pubmed/31194882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003506.pub2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares